
### [MONDO:0005089](http://purl.obolibrary.org/obo/MONDO_0005089)
**Label:** sarcoma

**Subclasses:** [MONDO:0017386](http://purl.obolibrary.org/obo/MONDO_0017386) (pleomorphic rhabdomyosarcoma), [MONDO:0002629](http://purl.obolibrary.org/obo/MONDO_0002629) (bone osteosarcoma), [MONDO:0016982](http://purl.obolibrary.org/obo/MONDO_0016982) (angiosarcoma (disease)), [MONDO:0009993](http://purl.obolibrary.org/obo/MONDO_0009993) (embryonal rhabdomyosarcoma (disease)), [MONDO:0013280](http://purl.obolibrary.org/obo/MONDO_0013280) (myxoid liposarcoma), [MONDO:0008977](http://purl.obolibrary.org/obo/MONDO_0008977) (chondrosarcoma (disease)), [MONDO:0006745](http://purl.obolibrary.org/obo/MONDO_0006745) (endometrial stromal sarcoma), [MONDO:0012817](http://purl.obolibrary.org/obo/MONDO_0012817) (Ewing sarcoma), [MONDO:0005212](http://purl.obolibrary.org/obo/MONDO_0005212) (rhabdomyosarcoma (disease)), [MONDO:0005058](http://purl.obolibrary.org/obo/MONDO_0005058) (leiomyosarcoma), [MONDO:0020561](http://purl.obolibrary.org/obo/MONDO_0020561) (myxoid/round cell liposarcoma), [MONDO:0005164](http://purl.obolibrary.org/obo/MONDO_0005164) (fibrosarcoma (disease)), [MONDO:0010434](http://purl.obolibrary.org/obo/MONDO_0010434) (synovial sarcoma (disease)), [MONDO:0005060](http://purl.obolibrary.org/obo/MONDO_0005060) (liposarcoma), 

**Corr. equiv. classes:** [OMIM:268210](http://purl.obolibrary.org/obo/OMIM_268210), [Orphanet:263413](http://www.orpha.net/ORDO/Orphanet_263413), [Orphanet:780](http://www.orpha.net/ORDO/Orphanet_780), [Orphanet:3273](http://www.orpha.net/ORDO/Orphanet_3273), [Orphanet:2030](http://www.orpha.net/ORDO/Orphanet_2030), [Orphanet:69078](http://www.orpha.net/ORDO/Orphanet_69078), [OMIM:300813](http://purl.obolibrary.org/obo/OMIM_300813), [Orphanet:213711](http://www.orpha.net/ORDO/Orphanet_213711), [Orphanet:293199](http://www.orpha.net/ORDO/Orphanet_293199), [Orphanet:64720](http://www.orpha.net/ORDO/Orphanet_64720), [OMIM:613488](http://purl.obolibrary.org/obo/OMIM_613488), [Orphanet:668](http://www.orpha.net/ORDO/Orphanet_668), [Orphanet:99757](http://www.orpha.net/ORDO/Orphanet_99757), [Orphanet:319](http://www.orpha.net/ORDO/Orphanet_319), [OMIM:612219](http://purl.obolibrary.org/obo/OMIM_612219), [Orphanet:99967](http://www.orpha.net/ORDO/Orphanet_99967), [OMIM:215300](http://purl.obolibrary.org/obo/OMIM_215300), [OMIM:259500](http://purl.obolibrary.org/obo/OMIM_259500), [Orphanet:55880](http://www.orpha.net/ORDO/Orphanet_55880), 

**Class expressions from DL-Learner:**

- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face))) 48.52%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head))) 48.52%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck))) 48.52%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system))) 48.51%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology))) 46.41%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument))) 45.43%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin))) 44.17%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0010614](http://purl.obolibrary.org/obo/HP_0010614) (Fibroma))) 43.18%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology))) 41.11%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion))) 40.27%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000112](http://purl.obolibrary.org/obo/HP_0000112) (Nephropathy))) 37.11%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) 36.49%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000018](http://purl.obolibrary.org/obo/HP_0000018) (null))) 36.49%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 36.49%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 36.49%


